论文部分内容阅读
目的观察小儿肺炎型哮喘的临床特点,提高对该病的认识。方法病例来自于2008年9月至2011年12月我院儿科门诊治疗具有肺炎特点哮喘患儿87例,予以抗哮喘为主要治疗,病情较重静脉点滴地塞米松,病情较轻吸入布地耐德混悬剂等药物作泵吸治疗,临床症状缓解后吸入丙酸倍氯米松气雾剂予以哮喘预防治疗,随访1年观察哮喘复发、反复呼吸道感染情况。其中吸入丙酸倍氯米松治疗56例患儿为观察组,拒绝吸入治疗31例患儿为对照组,采用χ2检验分析观察结果。结果 87例患儿经抗哮喘治疗后病情均被控制,治疗时间(8.39±4.27)d。随访1年后,观察组在哮喘复发、反复呼吸道感染改善方面明显好于对照组,差异有统计学意义(P<0.05)。结论正确判断肺炎型哮喘,及时进行抗哮喘治疗,病情缓解后,吸入药物进行干预治疗,能减少哮喘复发、改善反复呼吸道感染。
Objective To observe the clinical features of pediatric pneumonia and improve the understanding of the disease. Methods From September 2008 to December 2011, pediatric outpatient treatment of 87 children with asthma characterized by pneumonia was given anti-asthma treatment. Serious venous drip dexamethasone, Suspension and other drugs for pumping therapy, clinical symptoms after inhalation of beclomethasone propionate inhalation for asthma prevention and treatment, follow-up of 1-year observation of asthma recurrence, recurrent respiratory infections. Among them, 56 cases were treated with beclometasone dipropionate in the observation group and 31 cases in the control group were rejected by inhalation therapy. The results were analyzed by χ2 test. Results 87 cases of children treated with anti-asthma condition were controlled, treatment time (8.39 ± 4.27) d. One year after follow-up, the observation group was significantly better than the control group in asthma relapse and recurrent respiratory tract infections, the difference was statistically significant (P <0.05). Conclusions Proper diagnosis of pneumonia-type asthma, timely anti-asthma treatment, remission, inhalation of drugs for intervention, can reduce the recurrence of asthma and improve recurrent respiratory tract infections.